These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13783566)

  • 1. Pharmacologic aspects of monoamine oxidase inhibition.
    WEBB JL
    Am J Cardiol; 1960 Dec; 6():1112-6. PubMed ID: 13783566
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.
    SHORE PA; COHN VH
    Biochem Pharmacol; 1960 Oct; 5():91-5. PubMed ID: 13912256
    [No Abstract]   [Full Text] [Related]  

  • 3. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase inhibition.
    ROSENBLUM I; FERGUSON FC
    Clin Pharmacol Ther; 1960; 1():692-3. PubMed ID: 13743428
    [No Abstract]   [Full Text] [Related]  

  • 5. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A
    Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948
    [No Abstract]   [Full Text] [Related]  

  • 7. A method for measurement of monoamine oxidase inhibition in man: application to studies on hypertension.
    SJOERDSMA A; GILLESPIE L; UDENFRIEND S
    Ann N Y Acad Sci; 1959 Sep; 80():969-80. PubMed ID: 13831423
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase, psychoenergizers, and tranquilizers.
    FELDSTEIN A; HOAGLAND H; FREEMAN H
    Science; 1959 Aug; 130(3374):500. PubMed ID: 13822065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A; McGRATH WR
    Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
    [No Abstract]   [Full Text] [Related]  

  • 13. [Our experiences with monoamine oxidase inhibiting substances].
    TAUBER CG
    Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide.
    DEWHURST WG; PARE CM
    J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of adrenaline after blockade of monoamine oxidase and catechol-O-methyltransferase.
    DE SCHAEPDRYVER AF; KIRSHNER N
    Science; 1961 Feb; 133(3452):586-7. PubMed ID: 13720844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoamine liberators and monoamine oxidase inhibitors].
    LEUSEN I
    Psychiatr Neurol (Basel); 1960 Jul; 140():154-64. PubMed ID: 13761295
    [No Abstract]   [Full Text] [Related]  

  • 18. MONOAMINE oxidase inhibitors.
    Br Med J; 1959 Dec; 2(5161):1238. PubMed ID: 13856860
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereospecificity of monoamine oxidase inhibitors.
    PLETSCHER A; GEY KF
    Science; 1958 Oct; 128(3329):900-1. PubMed ID: 13592273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monoamine oxidase inhibitors].
    MACIAS CASTRO I
    Arch Hosp Univ; 1960; 12():330-3. PubMed ID: 13764845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.